# <div align=center> A Prediction of Number of Patients and Risk of Disease <br/> in Each Region Based on Pharmaceutical Prescription Data </div>

<div align=right> <img alt="GitHub repo size" src="https://img.shields.io/github/repo-size/HJK02130/Prediction-Num-of-Patients-and-Risk-of-Disease-Each-Region-Based-on-Pharmaceutical-Prescription-data?style=flat-square"> <img alt="GitHub code size in bytes" src="https://img.shields.io/github/languages/code-size/HJK02130/Prediction-Num-of-Patients-and-Risk-of-Disease-Each-Region-Based-on-Pharmaceutical-Prescription-data?style=flat-square"> <img alt="GitHub language count" src="https://img.shields.io/github/languages/count/HJK02130/Prediction-Num-of-Patients-and-Risk-of-Disease-Each-Region-Based-on-Pharmaceutical-Prescription-data?style=flat-square"> </div>


### Contents
1. [Overview](#overview)
2. [Requirements](#requirements)
3. [Languages and Development Tools](#languages-and-development-tools)
4. [Architecture](#architecture)
5. [Data](#data)
6. [Repository Explaination](#repository-explaination)
7. [Result](#result)
8. [Conclusion](#conclusion)
9. [Reference](#reference)
10. [Developer](#developer)


### Overview

In the news and various materials, the number of patients with a specific disease by region is statistical data from national health examination data. And it is not accurate data because not only the entire population does not participate, but also only those over a certain age regularly participate. In addition, there are many statistics on the number of patients divided by age, sex, etc., but statistics on the number of patients divided by region can only be found about the most common diseases.<br/><br/>

In this study, we predict the number of patients by region in 2018 for specific diseases. In addition, based on the number of analyzed patients, we predict the risk of occurrence of the disease by region and derive implications for the risk of the disease by region. For data analysis, we used drug prescription data from 2010 to 2017 of Korea, and predict the number of patients by region applying the 2018 drug prescription data through correlation analysis and regression analysis.<br/><br/>
  
First, we figure out the degree of association between a specific drug and various diseases for which the drug is effective through correlation analysis using Pearson's correlation coefficient. Thereafter, we obtain a linear regression equation that calculates the expected total number of patients with a disease highly related to the corresponding drug based on the number of prescriptions for the drug through a linear regression analysis between drugs and diseases with a high degree of relatedness. Finally, we substitute the number of drug prescriptions in 2018, the most recent data, into the linear regression equation and predict the number of patients with specific diseases in 2018 by region using a specific weight concept. Also we calculate the disease risk obtained by comparing with other regions. This project was carried out as an assignment at Kyung Hee University.<br/><br/>
  
ë‰´ìŠ¤ ë° ê°ì¢… ìë£Œì˜ ì§€ì—­ë³„ íŠ¹ì • ì§ˆë³‘ì˜ í™˜ì ìˆ˜ëŠ” êµ­ë¯¼ê±´ê°•ê²€ì§„ìë£Œë¡œë¶€í„° í†µê³„ëœ ìë£Œë¡œ, ì˜¨ êµ­ë¯¼ì´ ì°¸ì—¬í•˜ì§€ ì•Šì„ ë¿ë”ëŸ¬ íŠ¹ì • ì—°ë ¹ ì´ìƒë§Œ ì •ê¸°ì ìœ¼ë¡œ ì°¸ì—¬í•˜ê¸° ë•Œë¬¸ì— ì •í™•í•œ ìë£Œê°€ ì•„ë‹ˆë‹¤. ë˜í•œ, ì—°ë ¹, ì„±ë³„ ë“±ì„ ê¸°ì¤€ìœ¼ë¡œ ë‚˜ë‰˜ì–´ì§„ í™˜ì ìˆ˜ í†µê³„ëŠ” ë§ì´ ìˆì§€ë§Œ, ì§€ì—­ì„ ê¸°ì¤€ìœ¼ë¡œ ë‚˜ë‰˜ì–´ì§„ í™˜ì ìˆ˜ í†µê³„ëŠ” í”í•œ ì§ˆë³‘ì˜ ìë£Œë§Œ ì°¾ì•„ë³¼ ìˆ˜ ìˆë‹¤.<br/><br/>

ë³¸ ì—°êµ¬ì—ì„œëŠ” íŠ¹ì • ì§ˆë³‘ë“¤ì˜ 2018ë…„ ì§€ì—­ë³„ í™˜ì ìˆ˜ë¥¼ ì˜ˆì¸¡í•œë‹¤. ë˜, ë¶„ì„í•œ í™˜ì ìˆ˜ë¥¼ ë°”íƒ•ìœ¼ë¡œ í•´ë‹¹ ì§ˆë³‘ì— ëŒ€í•œ ë°œìƒ ìœ„í—˜ë„ë¥¼ ì§€ì—­ë³„ë¡œ ì˜ˆì¸¡í•˜ì—¬ ì§€ì—­ë³„ë¡œ ì§ˆë³‘ì— ëŒ€í•œ ìœ„í—˜ë„ì˜ ì‹œì‚¬ì ì„ ë„ì¶œí•œë‹¤. ë°ì´í„° ë¶„ì„ì„ ìœ„í•´ ëŒ€í•œë¯¼êµ­ì˜ 2010ë…„ì—ì„œ 2017ë…„ê¹Œì§€ì˜ ì˜ì•½í’ˆ ì²˜ë°© ë°ì´í„°ë¥¼ ê¸°ë°˜ìœ¼ë¡œ ìƒê´€ë¶„ì„ê³¼ íšŒê·€ë¶„ì„ì„ í†µí•´ ê°€ì¥ ìµœê·¼ ë°ì´í„°ì¸ 2018ë…„ ì˜ì•½í’ˆ ì²˜ë°© ë°ì´í„°ë¥¼ ì ìš©ì‹œì¼œ ì§€ì—­ë³„ í™˜ì ìˆ˜ë¥¼ ì˜ˆì¸¡í•œë‹¤.<br/><br/>

ìƒê´€ë¶„ì„ê³¼ íšŒê·€ë¶„ì„ì„ ì´ìš©í•˜ì—¬ ê²°ê³¼ë¥¼ ë„ì¶œí•˜ëŠ” ë°©ë²•ì€ ë‹¤ìŒê³¼ ê°™ë‹¤. ë¨¼ì €, Pearson ìƒê´€ê³„ìˆ˜ë¥¼ ì´ìš©í•œ ìƒê´€ë¶„ì„ì„ í†µí•´ íŠ¹ì • ì˜ì•½í’ˆê³¼ í•´ë‹¹ ì˜ì•½í’ˆì´ íš¨ê³¼ë¥¼ ë°œíœ˜í•˜ëŠ” ì—¬ëŸ¬ê°€ì§€ ì§ˆë³‘ë“¤ê³¼ì˜ ì—°ê´€ëœ ì •ë„(r)ë¥¼ íŒŒì•…í•œë‹¤. ì´í›„ ì—°ê´€ëœ ì •ë„ê°€ ë†’ê²Œ ëŒ€ì‘ë˜ëŠ” ì˜ì•½í’ˆê³¼ ì§ˆë³‘ë¼ë¦¬ì˜ ì„ í˜•íšŒê·€ë¶„ì„ì„ í†µí•´ ì˜ì•½í’ˆ ì²˜ë°©ê±´ìˆ˜ë¥¼ ë°”íƒ•ìœ¼ë¡œ í•´ë‹¹ ì˜ì•½í’ˆê³¼ ì—°ê´€ì„±ì´ ë†’ì€ ì§ˆë³‘ì˜ ì˜ˆìƒ ì´ í™˜ììˆ˜ë¥¼ ì‚°ì¶œí•˜ëŠ” ì„ í˜•íšŒê·€ì‹ì„ ì–»ëŠ”ë‹¤. ì„ í˜•íšŒê·€ì‹ì— ê°€ì¥ ìµœê·¼ ë°ì´í„°ì¸ 2018ë…„ë„ ì˜ì•½í’ˆ ì²˜ë°©ê±´ìˆ˜ ë°ì´í„°ë¥¼ ëŒ€ì…í•˜ê³  ê°€ì¤‘ì¹˜ ê°œë…ì„ ë„ì…í•˜ì—¬ 2018ë…„ ì§€ì—­ë³„ íŠ¹ì • ì§ˆë³‘ë“¤ì˜ í™˜ììˆ˜ë¥¼ ì˜ˆì¸¡í•˜ê³  ë§ˆì§€ë§‰ìœ¼ë¡œ ë‹¤ë¥¸ì§€ì—­ê³¼ ë¹„êµí•˜ì—¬ ì–»ì–´ì§„ ì§ˆë³‘ ë°œìƒ ìœ„í—˜ë„ë¥¼ ì‚°ì¶œí•œë‹¤.

### Requirements
+ Python 3.6

### Languages and Development Tools
<img src="https://img.shields.io/badge/Python-3766AB?style=flat-square&logo=Python&logoColor=white"/> <br />
<img src="https://img.shields.io/badge/Google Colab-F9AB00?style=flat-square&logo=GoogleColab&logoColor=white"/> <img src="https://img.shields.io/badge/Visual Studio Code-007ACC?style=flat-square&logo=VisualStudioCode&logoColor=white"/>

### Architecture
<div align=center>  <img src="./img/architecture.png"> </div>

### Data
+ 2010-2018 Pharmaceutical Prescription data (2010-2018 ì˜ì•½í’ˆ ì²˜ë°© ë°ì´í„°, ê³µê³µë°ì´í„°í¬í„¸, https://www.data.go.kr/index.do)
+ 2010-2018 Number of patients by 500 diseases with high frequency (2010-2018 ë‹¤ë¹ˆë„ 500ê°€ì§€ ì§ˆë³‘ë³„ í™˜ì ìˆ˜, ë³´ê±´ì˜ë£Œë¹…ë°ì´í„°ê°œë°©ì‹œìŠ¤í…œ, https://opendata.hira.or.kr/home.do)
+ 2010-2018 Population by region (2010-2018 ì§€ì—­ë³„ ì´ ì¸êµ¬ ìˆ˜, í†µê³„ì²­, https://kostat.go.kr/portal/korea/index.action)
+ Region Code (ì§€ì—­ì½”ë“œ)
<br/>

### Repository Explaination
###### ğŸ“„ correlation.py<br/> Correlation analysis between medicine and disease
###### ğŸ“„ preprocessing.py<br/> Data preprocessing
###### ğŸ“„ prediction.py<br/> Prediction of the number of patients by disease using linear regression and weight formula
###### ğŸ“„ regression.ipynb<br/> Regressiong analysis for prediction of the number of patients using 
###### ğŸ“„ transformation.py<br/> Data transforming
<br/>

### Result
[[ğŸ“½ Demo Video]](https://drive.google.com/file/d/1ZGazFyvy2vYYvYeUUHTiIFpL_58SCBsb/view?usp=share_link)

#### Example) Result of Correlation Analysis and Regression Analysis
+ Pearson correlation coefficient(r) between '428901ATB' and Acute Bronchitis <br/>
	r = 0.619
+ Linear regression equation to calculate expected number of Allergic Rhinitis patients by region <br/>
	y = 65.44x + 3022790.16 <br/>
	(x = Number of prescriptions, y= # of patients)<br/>
	<img src="./img/ex_regression.png">

<br/>

#### Prediction the number of patients and risk by region using the number of drug â€˜428901ATBâ€™ prescriptions
(rounded off the first decimal place)
+ Acute Bronchitis ê¸‰ì„±ê¸°ê´€ì§€ì—¼<br/>

|Region|Predicted the Number of Patients|Predicted Risk|Region|Predicted the Number of Patients|Predicted Risk|
|:---:|:---|:---|:---:|:---|:---|
|ì„œìš¸|882275|Low|ê²½ê¸°ë„|1002957|Medium|
|ë¶€ì‚°|959668|Low|ê°•ì›ë„|875971|Low|
|ëŒ€êµ¬|832368|Medium|ì¶©ì²­ë‚¨ë„|1175118|High|
|ì¸ì²œ|1037588|Medium|ì¶©ì²­ë¶ë„|1229743|High|
|ê´‘ì£¼|999680|Medium|ì „ë¼ë‚¨ë„|1097908|High|
|ëŒ€ì „|1280635|High|ì „ë¼ë¶ë„|1242750|Medium|
|ìš¸ì‚°|955434|Low|ê²½ìƒë‚¨ë„|975949|Low|
|ì„¸ì¢…|1084881|Medium|ê²½ìƒë¶ë„|923521|Medium|
<br/>
+ Chronic Bronchitis ë§Œì„±ê¸°ê´€ì§€ì—¼<br/>

|Region|Predicted the Number of Patients|Predicted Risk|Region|Predicted the Number of Patients|Predicted Risk|
|:---:|:---|:---|:---:|:---|:---|
|ì„œìš¸|21867|Low|ê²½ê¸°ë„|24858|Medium|
|ë¶€ì‚°|23785|Medium|ê°•ì›ë„|21710|Low|
|ëŒ€êµ¬|20630|Low|ì¶©ì²­ë‚¨ë„|30478|High|
|ì¸ì²œ|25716|Medium|ì¶©ì²­ë¶ë„|29125|High|
|ê´‘ì£¼|24776|Medium|ì „ë¼ë‚¨ë„|27211|Medium|
|ëŒ€ì „|31740|High|ì „ë¼ë¶ë„|30803|High|
|ìš¸ì‚°|23680|Medium|ê²½ìƒë‚¨ë„|24188|Medium|
|ì„¸ì¢…|26888|Medium|ê²½ìƒë¶ë„|22889|Low|
<br/>

#### Prediction the number of patients and risk by region using the number of drug â€˜220902ATBâ€™ prescriptions
+ Chronic Sinusitis ë§Œì„±ë¶€ë¹„ë™ì—¼<br/>

|Region|Predicted the Number of Patients|Predicted Risk|Region|Predicted the Number of Patients|Predicted Risk|
|:---:|:---|:---|:---:|:---|:---|
|ì„œìš¸|138638|Medium|ê²½ê¸°ë„|171180|High|
|ë¶€ì‚°|123031|Low|ê°•ì›ë„|112066|Low|
|ëŒ€êµ¬|102705|Low|ì¶©ì²­ë‚¨ë„|137747|Medium|
|ì¸ì²œ|146682|Medium|ì¶©ì²­ë¶ë„|153178|Medium|
|ê´‘ì£¼|158958|Medium|ì „ë¼ë‚¨ë„|127405|Medium|
|ëŒ€ì „|157997|Medium|ì „ë¼ë¶ë„|125457|Medium|
|ìš¸ì‚°|125870|Medium|ê²½ìƒë‚¨ë„|138524|Medium|
|ì„¸ì¢…|233242|High|ê²½ìƒë¶ë„|99805|Low|

+ Allergic Rhinitis ì•ŒëŸ¬ì§€ì„±ë¹„ì—¼ <br/>

|Region|Predicted the Number of Patients|Predicted Risk|Region|Predicted the Number of Patients|Predicted Risk|
|:---:|:---|:---|:---:|:---|:---|
|ì„œìš¸|428580|Medium|ê²½ê¸°ë„|529180|High|
|ë¶€ì‚°|380333|Low|ê°•ì›ë„|346438|Low|
|ëŒ€êµ¬|317499|Low|ì¶©ì²­ë‚¨ë„|425825|Medium|
|ì¸ì²œ|453448|Medium|ì¶©ì²­ë¶ë„|473529|High|
|ê´‘ì£¼|491398|High|ì „ë¼ë‚¨ë„|393856|Low|
|ëŒ€ì „|488426|Medium|ì „ë¼ë¶ë„|387833|Low|
|ìš¸ì‚°|389110|Medium|ê²½ìƒë‚¨ë„|428230|Medium|
|ì„¸ì¢…|721037|High|ê²½ìƒë¶ë„|308532|Low|

<br/>

#### Prediction the number of patients and risk by region using the number of drug â€˜186101ATBâ€™ prescriptions
+ Benign Rheumatoid Arthritis ì§€ì—­ë³„ ì–‘ì„± ë¥˜ë§ˆí‹°ìŠ¤ê´€ì ˆì—¼ í™˜ììˆ˜ ì˜ˆì¸¡<br/>

|Region|Predicted the Number of Patients|Predicted Risk|Region|Predicted the Number of Patients|Predicted Risk|
|:---:|:---|:---|:---:|:---|:---|
|ì„œìš¸|6701|Low|ê²½ê¸°ë„|6615|Low|
|ë¶€ì‚°|6885|Low|ê°•ì›ë„|6259|Low|
|ëŒ€êµ¬|8250|Medium|ì¶©ì²­ë‚¨ë„|7705|Medium|
|ì¸ì²œ|7456|Medium|ì¶©ì²­ë¶ë„|10016|High|
|ê´‘ì£¼|5752|Low|ì „ë¼ë‚¨ë„|8568|High|
|ëŒ€ì „|8118|Medium|ì „ë¼ë¶ë„|7599|Medium|
|ìš¸ì‚°|9222|High|ê²½ìƒë‚¨ë„|7171|Medium|
|ì„¸ì¢…|7886|Medium|ê²½ìƒë¶ë„|9205|High|

<br/>

+ Prostate Cancer ì „ë¦½ì„ ì•”<br/>

|Region|Predicted the Number of Patients|Predicted Risk|Region|Predicted the Number of Patients|Predicted Risk|
|:---:|:---|:---|:---:|:---|:---|
|ì„œìš¸|5415|Medium|ê²½ê¸°ë„|5345|Low|
|ë¶€ì‚°|5564|Medium|ê°•ì›ë„|5058|Low|
|ëŒ€êµ¬|6667|Medium|ì¶©ì²­ë‚¨ë„|6227|Medium|
|ì¸ì²œ|6026|Medium|ì¶©ì²­ë¶ë„|8094|High|
|ê´‘ì£¼|4648|Low|ì „ë¼ë‚¨ë„|6924|High|
|ëŒ€ì „|6560|Medium|ì „ë¼ë¶ë„|6141|Medium|
|ìš¸ì‚°|7452|High|ê²½ìƒë‚¨ë„|5795|Medium|
|ì„¸ì¢…|6373|Medium|ê²½ìƒë¶ë„|6631|Medium|

<br/>

+ Lung Cancer íì•”<br/>

|Region|Predicted the Number of Patients|Predicted Risk|Region|Predicted the Number of Patients|Predicted Risk|
|:---:|:---|:---|:---:|:---|:---|
|ì„œìš¸|7014|Low|ê²½ê¸°ë„|6923|Low|
|ë¶€ì‚°|7207|Low|ê°•ì›ë„|6551|Low|
|ëŒ€êµ¬|8635|High|ì¶©ì²­ë‚¨ë„|8064|Medium|
|ì¸ì²œ|7804|Medium|ì¶©ì²­ë¶ë„|10483|High|
|ê´‘ì£¼|6020|Low|ì „ë¼ë‚¨ë„|8967|High|
|ëŒ€ì „|8497|Medium|ì „ë¼ë¶ë„|7954|Medium|
|ìš¸ì‚°|9652|High|ê²½ìƒë‚¨ë„|7506|Medium|
|ì„¸ì¢…|8254|Medium|ê²½ìƒë¶ë„|8588|Medium|

<br/>

#### Prediction the number of patients and risk by region using the number of drug â€˜421001ATBâ€™ prescriptions
+ Vomiting êµ¬ì—­ ë° êµ¬í† <br/>

|Region|Predicted the Number of Patients|Predicted Risk|Region|Predicted the Number of Patients|Predicted Risk|
|:---:|:---|:---|:---:|:---|:---|
|ì„œìš¸|34722|Low|ê²½ê¸°ë„|34444|Low|
|ë¶€ì‚°|46212|Medium|ê°•ì›ë„|27927|Low|
|ëŒ€êµ¬|42611|Medium|ì¶©ì²­ë‚¨ë„|42789|Medium|
|ì¸ì²œ|39391|Medium|ì¶©ì²­ë¶ë„|48835|High|
|ê´‘ì£¼|29709|Low|ì „ë¼ë‚¨ë„|43977|Medium|
|ëŒ€ì „|46118|Medium|ì „ë¼ë¶ë„|42465|Medium|
|ìš¸ì‚°|43158|Medium|ê²½ìƒë‚¨ë„|44007|Medium|
|ì„¸ì¢…|34728|Low|ê²½ìƒë¶ë„|42171|Medium|

<br/>

#### Prediction the number of patients and risk by region using the number of drug â€˜133301ATBâ€™ prescriptions
+ Gastric Ulcer ìœ„ê¶¤ì–‘<br/>

|Region|Predicted the Number of Patients|Predicted Risk|Region|Predicted the Number of Patients|Predicted Risk|
|:---:|:---|:---|:---:|:---|:---|
|ì„œìš¸|57418|Medium|ê²½ê¸°ë„|55455|Low|
|ë¶€ì‚°|73510|High|ê°•ì›ë„|49604|Low|
|ëŒ€êµ¬|66547|Medium|ì¶©ì²­ë‚¨ë„|56827|Low|
|ì¸ì²œ|50732|Low|ì¶©ì²­ë¶ë„|85209|High|
|ê´‘ì£¼|71837|Medium|ì „ë¼ë‚¨ë„|81346|High|
|ëŒ€ì „|66150|Medium|ì „ë¼ë¶ë„|68728|Medium|
|ìš¸ì‚°|64708|Medium|ê²½ìƒë‚¨ë„|71195|Medium|
|ì„¸ì¢…|60889|Medium|ê²½ìƒë¶ë„|73518|High|

<br/>

+ Duodenal Ulcer ì‹­ì´ì§€ì¥ê¶¤ì–‘<br/>

|Region|Predicted the Number of Patients|Predicted Risk|Region|Predicted the Number of Patients|Predicted Risk|
|:---:|:---|:---|:---:|:---|:---|
|ì„œìš¸|15826|Medium|ê²½ê¸°ë„|15285|Medium|
|ë¶€ì‚°|20261|Medium|ê°•ì›ë„|13672|Low|
|ëŒ€êµ¬|18342|Medium|ì¶©ì²­ë‚¨ë„|15663|Medium|
|ì¸ì²œ|13983|Low|ì¶©ì²­ë¶ë„|23486|High|
|ê´‘ì£¼|19800|Medium|ì „ë¼ë‚¨ë„|22421|High|
|ëŒ€ì „|18233|Medium|ì „ë¼ë¶ë„|18943|Medium|
|ìš¸ì‚°|17835|Medium|ê²½ìƒë‚¨ë„|20263|Medium|
|ì„¸ì¢…|16783|Medium|ê²½ìƒë¶ë„|19623|Medium|

<br/>

#### Prediction the number of patients and risk by region using the number of drug â€˜271800ATBâ€™ prescriptions
+ Gastroesophageal Reflux Disease(GERD) ìœ„-ì‹ë„ ì—­ë¥˜ë³‘<br/>

|Region|Predicted the Number of Patients|Predicted Risk|Region|Predicted the Number of Patients|Predicted Risk|
|:---:|:---|:---|:---:|:---|:---|
|ì„œìš¸|253563|Low|ê²½ê¸°ë„|255375|Low|
|ë¶€ì‚°|274219|Medium|ê°•ì›ë„|327428|Medium|
|ëŒ€êµ¬|284450|Medium|ì¶©ì²­ë‚¨ë„|334029|High|
|ì¸ì²œ|263656|Medium|ì¶©ì²­ë¶ë„|241523|Low|
|ê´‘ì£¼|315621|Medium|ì „ë¼ë‚¨ë„|397093|High|
|ëŒ€ì „|287140|Medium|ì „ë¼ë¶ë„|321126|Medium|
|ìš¸ì‚°|261124|Low|ê²½ìƒë‚¨ë„|347909|High|
|ì„¸ì¢…|246327|Medium|ê²½ìƒë¶ë„|291975|Medium|


### Conclusion
In the recommendation system, we implemented a total of three recommendation systems: content-based, association rule-based, and thumbnail image-based. Unlike existing YouTube, the recommendation system has been diversified, and users can check the system.<br/></br>
Also, This application was developed by interconnecting three: python-firebase-flutter. It's rarecase in which all these three are linked, and since all are free distribution, it is meaningful in that reduced development costs.<br/><br/>
By implementing text summarization, it not only provides users with a simple YouTube video viewing platform, but also provides video summary information. It is meaningful in that it provides additional information for selection, not just video recommendation, to a user who selects a video to watch for learning purposes.<br/><br/>
The application created through this project is expected to increase added value and build a new learning platform by contributing close to the essence of shared content. In addition, based on the above, it is expected to create a new market for low-cost app development that links three tools using free distribution tools and sources. Lastly, if the scope is expanded to parascience and medical science, it is expected that students from socially disadvantaged classes will be able to study by finding high-quality lecture contents.

### Reference
+ ì´ìƒìš©. (2016). ì˜ì•½í’ˆì²˜ë°©ì •ë³´ ê³µê³µë°ì´í„° ë¶„ì„ì„ í†µí•œ ì¶©ë¶ì˜ íŠ¹ì„± ë° ì‹œì‚¬ì . ì¶©ë¶ FOCUS, 120, 1-22.
+ ì•½í•™ì •ë³´ì› ì˜ì•½í’ˆ ê²€ìƒ‰ ì‹œìŠ¤í…œ, https://www.health.kr/searchDrug/search_detail.asp
+ ê±´ê°•ë³´í—˜ì‹¬ì‚¬í‰ê°€ì› ì˜ë£Œì •ë³´ê´€ë¦¬ë¶€. (2018). ìƒí™œì† ì§ˆë³‘í†µê³„ 100ì„ , https://repository.hira.or.kr/handle/2019.oak/1273

### Developer
Hyunji Kim
<br />
<a href="mailto:hjk021@khu.ac.kr"> <img src ="https://img.shields.io/badge/Gmail-EA4335.svg?&style=flat-squar&logo=Gmail&logoColor=white"/> 
	[<img src="https://img.shields.io/badge/Notion-000000?style=flat-square&logo=Notion&logoColor=white"/>](https://read-me.notion.site/Hyunji-Kim-9dbdb62cc84347feb85b3c58225bb63b)
	<a href = "https://github.com/HJK02130"> <img src ="https://img.shields.io/badge/Github-181717.svg?&style=flat-squar&logo=Github&logoColor=white"/> </a>
